Primary focal hyperhidrosis and autonomic symptom burden: a case-control study using the COMPASS-31 questionnaire
- PMID: 41388201
- DOI: 10.1007/s10286-025-01178-w
Primary focal hyperhidrosis and autonomic symptom burden: a case-control study using the COMPASS-31 questionnaire
Abstract
Purpose: To explore the relationship between primary focal hyperhidrosis (PFH) and generalized autonomic dysfunction, we assessed autonomic symptom burden using a comprehensive and validated measure of autonomic symptoms.
Methods: In this case-control study, we compared 132 patients with PFH with 74 matched healthy controls. Autonomic symptoms were assessed using the Composite Autonomic Symptom Score-31 (COMPASS-31) questionnaire. Propensity score matching minimized confounding. Mann-Whitney U tests compared COMPASS-31 scores between groups. A sensitivity analysis using multivariate linear regression accounted for specific hyperhidrosis sites and demographic factors.
Results: PFH cases demonstrated significantly higher median COMPASS-31 scores compared to controls (18.7 [IQR 7.7-34.8] vs. 11.2 [IQR 3.5-19.3], p < 0.001). Significant differences were observed in orthostatic (2.0 [0-20] vs. 0 [0-12], p = 0.028), vasomotor (0 [0-0] vs. 0 [0-0], p = 0.005; 24.2% vs. 9.5% non-zero scores, respectively), secretomotor (3.2 [2.1-8.6] vs. 0 [0-3.8], p < 0.001), and gastrointestinal (5.4 [1.8-8] vs. 1.8 [0.9-5.4], p = 0.004) domains. Sensitivity analysis confirmed PFH status as a significant predictor of higher COMPASS-31 scores (additional 7.5 points on average, 95% CI 1.6-13.4, p = 0.012) after adjusting for demographic factors and hyperhidrosis sites. Craniofacial and truncal hyperhidrosis were associated with higher autonomic symptom burden.
Conclusion: PFH is associated with a broader spectrum of autonomic symptoms beyond localized sweating, establishing a link to more generalized autonomic dysfunction. These findings underscore the need for a comprehensive approach to evaluating and managing patients with PFH.
Keywords: Autonomic dysfunction; COMPASS-31; Case–control study; Dysautonomia; Primary focal hyperhidrosis; Sympathetic nervous system.
© 2025. Springer-Verlag GmbH Germany.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare that they have no conflict of interest.
References
-
- Naumann M, Hamm H, Spalding J, Kowalski J, Lee J (2003) Comparing the quality of life effect of primary focal hyperhidrosis as assessed by the Dermatology Life Quality Index (DLQI). In: July 2003 meeting of the American Academy of Dermatology
-
- Kjeldstrup Kristensen J, Grejsen D, Swartling C, Bygum A (2020) In hyperhidrosis quality of life is even worse than in acne, eczema, or psoriasis. A comparison of Skindex-16 and dermatology life quality index (DLQI). Int J Dermatol 59(11):e392–e393. https://doi.org/10.1111/ijd.15164 - DOI - PubMed
-
- Cina CS, Clase CM (1999) The illness intrusiveness rating scale: a measure of severity in individuals with hyperhidrosis. Qual Life Res 8(8):693–698. https://doi.org/10.1023/a:1008968401068 - DOI - PubMed
-
- Sato K, Kang WH, Saga K, Sato KT (1989) Biology of sweat glands and their disorders. II. Disorders of sweat gland function. J Am Acad Dermatol 20(5 Pt 1):713–726. https://doi.org/10.1016/s0190-9622(89)70081-5 - DOI - PubMed
-
- Johnson R, Spaulding J (1974) Disorders of the autonomic nervous system. Chapter 10. Sweating. Contemp Neurol Ser (11):179–98
Grants and funding
LinkOut - more resources
Full Text Sources
